St. Jude Medical Inc. has temporarily pulled its Brio deep brain stimulation implantable pulse generator off the market in Europe, Australia and Latin America due to a “fixable” problem, the firm said April 2. The device, launched in 2010, treats symptoms in patients with Parkinson’s disease. St. Jude received 11 reports of Brio “exhibiting lower than expected impedance of readings leading to therapy degradation.” In eight of the patients, the device was explanted and a new one was implanted, the company said. Currently, 400 patients have the device in Europe. St. Jude has issued a product field corrective action and expects Brio to be unavailable for 60-90 days while the problem is addressed, but hopes for it to be available again “as soon as possible, subject to any applicable regulatory approvals.” The product has not received U.S. approval.
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?